PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer

Overview of attention for article published in Frontiers in endocrinology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 31,920 followers.

RT @FrontEndocrinol: New Research: PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzuma…

18 Oct 2022

Reply Repost Favourite

New Research: PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer: Protein expression, activation and stability are regulated through… https://t.co/AgJY7Fu3kQ #

18 Oct 2022

Reply Repost Favourite

Well done Jeanesse for the high-impact publication. A great achievement that puts together all the hard work done during your PhD studies. The project was funded by ALIVE Charity Foundation. #breastcancer #breastcancerresearch #pr… target="_blank" href="https://t.co/vs8xslfThT">https://t.co/vs8xslfThT

18 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.